hizentra
csl behring gmbh - human normal immunoglobulin (scig) - immunologic deficiency syndromes - immune sera and immunoglobulins, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4.4).- secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of
cuvitru solution
takeda canada inc - immunoglobulin (human) - solution - 200mg - immunoglobulin (human) 200mg - serums
subcuvia 1.6g/10ml solution for injection vials
baxalta uk ltd - normal immunoglobulin human - solution for injection - 160mg/1ml
subcuvia 800mg/5ml solution for injection vials
baxalta uk ltd - normal immunoglobulin human - solution for injection - 160mg/1ml
gammanorm 2g/12ml solution for injection vials
octapharma ltd - normal immunoglobulin human - solution for injection - 165mg/1ml
gammanorm 4g/24ml solution for injection vials
octapharma ltd - normal immunoglobulin human - solution for injection - 165mg/1ml
gammanorm 8g/48ml solution for injection vials
octapharma ltd - normal immunoglobulin human - solution for injection - 165mg/1ml
gammanorm 1g/6ml solution for injection vials
octapharma ltd - normal immunoglobulin human - solution for injection - 165mg/1ml
cuvitru 1g/5ml solution for infusion vials
takeda uk ltd - normal immunoglobulin human - solution for infusion - 200mg/1ml
gammanorm solution for injection 165mg/ml (10ml vial)
octapharma (ip) limited - human normal immunoglobulin - solution for injection - human normal immunoglobulin 165 mg/ml - immune sera and immunoglobulins